Net loss of Nath Bio-Genes (India) reported to Rs 0.01 crore in the quarter ended March 2026 as against net profit of Rs 1.48 crore during the previous quarter ended March 2025. Sales declined 0.73% to Rs 51.59 crore in the quarter ended March 2026 as against Rs 51.97 crore during the previous quarter ended March 2025.
For the full year,net profit rose 7.85% to Rs 41.63 crore in the year ended March 2026 as against Rs 38.60 crore during the previous year ended March 2025. Sales rose 21.98% to Rs 445.10 crore in the year ended March 2026 as against Rs 364.91 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 51.59 | 51.97 | -1 | 445.10 | 364.91 | 22 |
| OPM % | 8.68 | 0.81 | - | 11.78 | 13.64 | - |
| PBDT | 2.26 | 2.91 | -22 | 44.26 | 43.86 | 1 |
| PBT | 1.23 | 1.57 | -22 | 40.29 | 40.04 | 1 |
| NP | -0.01 | 1.48 | PL | 41.63 | 38.60 | 8 |
Powered by Capital Market - Live News
